All sources › BioSpace
BioSpace
1 article attributed to BioSpace on The San Antonio.
Avenzo Therapeutics to Present Preliminary Phase 1 Results from ORION-1 Study of AVZO-023, a Selective CDK4 Inhibitor, at the 2026 San Antonio Breast Cancer Symposium
Nov 2, 2026